Federico
Martinón Torres
![Foto de Federico](/img/nophoto.png)
![Foto de Duke Clinical Research Institute](/img/noimage_org.png)
Duke Clinical Research Institute
Durham, Estados UnidosPublications in collaboration with researchers from Duke Clinical Research Institute (1)
2022
-
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Journal of Neurodevelopmental Disorders, Vol. 14, Núm. 1